News

Published on 28 Feb 2024 on Insider Monkey via Yahoo Finance

Reasons for the Decline of Illumina (ILMN)


Article preview image

Baron Funds, an investment management company, released its “Baron Opportunity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund rose 15.10% (Institutional Shares), outperformed the Russell 3000 Growth Index, which gained 14.09%, and the S&P 500 Index, which advanced 11.69%. The fund saw a significant increase of almost 50% for the entire year, which was substantially higher than both indexes. It was a strong recovery after a challenging 2022. In addition, please check the fund’s top five holdings to know its best picks in 2023.

Baron Opportunity Fund featured stocks like Illumina, Inc. (NASDAQ:ILMN) in the fourth quarter 2023 investor letter. Headquartered in San Diego, California, Illumina, Inc. (NASDAQ:ILMN) offers life science tools and integrated systems for for genetic and genomic analysis. On February 27, 2024, Illumina, Inc. (NASDAQ:ILMN) stock closed at $139.76 per share. One-month return of Illumina, Inc. (NASDAQ:ILMN) was -2.27%, and its shares lost 29.61% of their value over the last 52 weeks. Illumina, Inc. (NASDAQ:ILMN) has a market capitalization of $22.208 billion.

Baron Opportunity Fund stated the following regarding Illumina, Inc. (NASDAQ:ILMN) in its fourth quarter 2023 investor letter:

NASDAQ.ILMN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Illumina (NASDAQ:ILMN) investors are sitting on a loss of 71% if they invested three years ago

As every investor would know, not every swing hits the sweet spot. But you have a problem if you ...

Simply Wall St. via Yahoo Finance 23 Apr 2024

Congressman Michael Burgess sells Exxon Mobil and Illumina stocks By Investing.com

In a recent congressional trade report, it has been revealed that Michael C. Burgess, the...

Investing.com 11 Apr 2024

Summit Therapeutics appoints genomics expert to board

Summit Therapeutics Inc. ( NASDAQ : NASDAQ: SMMT ) announced the immediate appointment of Mostafa...

Investing.com 11 Apr 2024

Is Illumina, Inc. (NASDAQ:ILMN) Trading At A 36% Discount?

Key Insights Illumina's estimated fair value is US$210 based on 2 Stage Free Cash Flow to EquityI...

Simply Wall St. via Yahoo Finance 29 Mar 2024

Illumina stock gains as EU court advisor backs Grail deal

Illumina (NASDAQ:ILMN) shares gained in the premarket Thursday after an advisor to the EU's top...

Seeking Alpha 21 Mar 2024

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

Making its debut on 11/01/2006, smart beta exchange traded fund Invesco S&P 500 Equal Weight Heal...

Zacks via Yahoo Finance 18 Mar 2024

Labcorp (LH) Presents New Research on Precision Diagnostics

Laboratory Corporation of America Holdings, Inc. or Labcorp LH recently highlighted results from ...

Zacks via Yahoo Finance 18 Mar 2024

Should Invesco S&P 500 Equal Weight ETF (RSP) Be on Your Investing Radar?

The Invesco S&P 500 Equal Weight ETF (RSP) was launched on 04/24/2003, and is a passively managed...

Zacks via Yahoo Finance 1 Mar 2024

Is Invesco S&P 500 Equal Weight ETF (RSP) a Strong ETF Right Now?

Making its debut on 04/24/2003, smart beta exchange traded fund Invesco S&P 500 Equal Weight ETF ...

Zacks via Yahoo Finance 28 Feb 2024

Reasons for the Decline of Illumina (ILMN)

Baron Funds, an investment management company, released its “Baron Opportunity Fund” fourth quart...

Insider Monkey via Yahoo Finance 28 Feb 2024